Global Subdermal Contraceptive Implants Market, By Type (Etonogestrel Implant, Levonorgestrel Implant, Others), Application (Hospital, Clinic, Research Facilities) – Industry Trends and Forecast to 2029
Market Analysis and Size
Advantages of subdermal contraceptive implant include long-term contraceptive action without requiring the provider's or user's attention, low dose of highly effective contraception without the use of estrogen, and fertility is readily reversible after the removal of implant. According to Centres for Disease Control, in 2017, more than 40 million women in the U.S. were using at least one method of contraception.
- Data Bridge Market Research analyses that the subdermal contraceptive implants market is expected to reach the value of USD 1,068.23 million by 2029, at a CAGR of 3.32% during the forecast period of 2022-2029. “Etonogestrel Implant” segment accounted for the largest share of the global subdermal contraceptive implants market owing to the rising number of hospitals.
Subdermal contraceptive implant is a tiny, thin rod about the size of a matchstick. The implant releases hormones slow and stable into the body to prevent pregnancy. Subdermal contraceptive implant helps to prevent pregnancy for one to five years. The protection period depends upon specific progestin and the type of polymer.
Subdermal Contraceptive Implants Market Dynamics
Increasing awareness about the sexual health and family planning
Governments and many agencies are providing sex education on school level and helping people to get to know their options and it driving the market.
Increasing unintended pregnancies
With growing population the cases of unwanted pregnancies are also rising it is caused by lack of education or precautions that can help to put a stop at unintended pregnancies and it is driving the market.
Rising awareness among population about the contraceptives
With growing population the cases of unwanted pregnancies are also rising that’s why awareness about contraceptives is very important and government started many campaigns and it is driving the market.
Rising government initiatives
Government is trying with approach to educate teenagers to aware about contraceptives by giving them sex education courses in their high school and it is driving the market.
Additionally, the increasing abortion rates, and technological advancement which decreases the
Furthermore, advancements in software technology extend profitable opportunities to the market players in the forecast period of 2022 to 2029.
On the other hand, increasing rate of infertility and rising awareness about the side effects of the contraceptive are expected to obstruct market growth. Also, privacy concerns and lack of sex education are projected to challenge the subdermal contraceptive implants market in the forecast period of 2022-2029.
This subdermal contraceptive implants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the subdermal contraceptive implants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Subdermal Contraceptive Implants Market
Covid-19 affecting the world with new infections and new diseases with millions of deaths and thousands waiting in line get checked many suffering from anxiety, depression and the negative effects on families who have to stay in isolation just get safety from this pandemic. It is very badly affecting the healthcare system all around the world and the impact of Covid-19 on subdermal contraceptive implants are even worse because families are spending more time with each other coping each other with intimacy and because they can’t get these implants because they can’t visit hospital they have the fear get infected and it is very badly effecting the market in the forecast period.
Global Subdermal Contraceptive Implants Market Scope
The subdermal contraceptive implants market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Etonogestrel implant
- Levonorgestrel implant
On the basis of type, the subdermal contraceptive implants market is segmented into etonogestrel implant, levonorgestrel implant and others.
- Research facilities
Based on application, the subdermal contraceptive implants market is divided into hospital, clinic, and research facilities.
Subdermal Contraceptive Implants Market Regional Analysis/Insights
The subdermal contraceptive implants market is analysed and market size insights and trends are provided by country, type and application as referenced above.
The countries covered in the subdermal contraceptive implants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the subdermal contraceptive implants market due to increasing awareness about contraceptives, and rising disposable income within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to growing initiatives taken by the government in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The subdermal contraceptive implants market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for subdermal contraceptive implants market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the subdermal contraceptive implants market. The data is available for historic period 2010-2020.
Competitive Landscape and Subdermal Contraceptive Implants Market Share Analysis
The subdermal contraceptive implants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to subdermal contraceptive implants market.
Some of the major players operating in the subdermal contraceptive implants market are Merck & Co., Inc., Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, BD, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, Sandoz International GmbH, Terumo Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., SHL Medical AG, Insulet Corporation and E3D Elcam Drug Delivery Devices among others.